Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide.

Publication ,  Journal Article
Schneider, G; Reker, D; Chen, T; Hauenstein, K; Schneider, P; Altmann, K-H
Published in: Angewandte Chemie (International Ed. in English)
September 2016

The cyclodepsipeptide doliculide is a marine natural product with strong actin-polymerizing and anticancer activities. Evidence for doliculide acting as a potent and subtype-selective antagonist of prostanoid E receptor 3 (EP3) is presented. Computational target prediction suggested that this membrane receptor is a likely macromolecular target and enabled immediate in vitro validation. This proof-of-concept study demonstrates the in silico deorphanization of phenotypic screening hits as a viable concept for future natural-product-inspired chemical biology and drug discovery efforts.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Angewandte Chemie (International Ed. in English)

DOI

EISSN

1521-3773

ISSN

1433-7851

Publication Date

September 2016

Volume

55

Issue

40

Start / End Page

12408 / 12411

Related Subject Headings

  • Receptors, Prostaglandin E, EP3 Subtype
  • Organic Chemistry
  • Ligands
  • Kinetics
  • Humans
  • HEK293 Cells
  • Drug Design
  • Depsipeptides
  • Biological Products
  • 03 Chemical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Schneider, G., Reker, D., Chen, T., Hauenstein, K., Schneider, P., & Altmann, K.-H. (2016). Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide. Angewandte Chemie (International Ed. in English), 55(40), 12408–12411. https://doi.org/10.1002/anie.201605707
Schneider, Gisbert, Daniel Reker, Tao Chen, Kurt Hauenstein, Petra Schneider, and Karl-Heinz Altmann. “Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide.Angewandte Chemie (International Ed. in English) 55, no. 40 (September 2016): 12408–11. https://doi.org/10.1002/anie.201605707.
Schneider G, Reker D, Chen T, Hauenstein K, Schneider P, Altmann K-H. Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide. Angewandte Chemie (International Ed in English). 2016 Sep;55(40):12408–11.
Schneider, Gisbert, et al. “Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide.Angewandte Chemie (International Ed. in English), vol. 55, no. 40, Sept. 2016, pp. 12408–11. Epmc, doi:10.1002/anie.201605707.
Schneider G, Reker D, Chen T, Hauenstein K, Schneider P, Altmann K-H. Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide. Angewandte Chemie (International Ed in English). 2016 Sep;55(40):12408–12411.
Journal cover image

Published In

Angewandte Chemie (International Ed. in English)

DOI

EISSN

1521-3773

ISSN

1433-7851

Publication Date

September 2016

Volume

55

Issue

40

Start / End Page

12408 / 12411

Related Subject Headings

  • Receptors, Prostaglandin E, EP3 Subtype
  • Organic Chemistry
  • Ligands
  • Kinetics
  • Humans
  • HEK293 Cells
  • Drug Design
  • Depsipeptides
  • Biological Products
  • 03 Chemical Sciences